期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肝癌肝移植适应证的探索 被引量：3

暂未订购
导出
作者 樊嘉 徐泱
机构地区 复旦大学附属中山医院肝外科复旦大学肝癌研究所
出处 《肝胆胰外科杂志》 CAS 2007年第1期1-3,共3页 Journal of Hepatopancreatobiliary Surgery
基金 国家自然科学基金资助项目(30500594)
关键词 肝肿瘤 肝移植 适应证
分类号 R735.7 [医药卫生—肿瘤] R657.3 [医药卫生—外科学]
  • 相关文献

参考文献18

  • 1樊嘉,徐泱,周俭.肝癌患者肝移植适应证的选择[J].中华医学杂志,2005,85(24):1662-1664. 被引量：23
  • 2Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics 2002[J].CA Cancer J Clin,2005,55(2):74-108.
  • 3Tang ZY,Ye SL,Liu YK,et al.Adecade's studies on metastasis of hepatocellular carcinoma[J].J Cancer Res Clin Oncol,2004,130(4):187-196.
  • 4Mazzaferro V,Regalia E,Doci R,et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J].N Engl J Med,1996,334(11):693-699.
  • 5Leung JY,Zhu AX,Gordon FD,et al.Liver transplantation outcomes for early-stage hepatocellular carcinoma:results of a multicenter study[J].Liver Transpl,2004,10(11):1343-1354.
  • 6Lee KW,Park JW,Joh JW,et al.Can we expand the Milan criteria for hepatocellular carcinoma in living donor liver transplantation?[J].Transplant Proc,2004,36 (8):2289-2290.
  • 7Marsh JW,Dvorchik I,Bonham CA,et al.Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?[J].Cancer,2000,88(1):538-543.
  • 8Yao FY,Ferrell L,Bass NM,et al.Liver transplantation for hepatocellular carcinoma:expansion of the tumor size limits does not adversely impact survival[J].Hepatology,2001,33(6):1394-1403.
  • 9Shetty K,Timmins K,Brensinger C,et al.Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome[J].Liver Transpl,2004,10(7):911-918.
  • 10Fernandez JA,Robles R,Marin C,et al.Can we expand the indications for liver transplantation among hepatocellular carcinoma patients with increased tumor size?[J].Transplant Proc,2003,35(5):1818-1820.

二级参考文献30

  • 1Tang ZY, Ye SL, Liu YK, et al. A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol,2004,130:187-196.
  • 2Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med,1996,334:693-699.
  • 3Leung JY, Zhu AX, Gordon FD, et al. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl, 2004,10:1343-1354.
  • 4Margarit C, Charco R, Hidalgo E, et al.. Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg,2002,26:257-263.
  • 5Khakhar A, Solano E, Stell D, et al. Survival after liver transplantation for hepatocellular carcinoma. Transplant Proc,2003,35:2438-2441.
  • 6Marsh JW, Dvorchik I, Bonham CA, et al. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer, 2000,88:538-543.
  • 7Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology,2001,33:1394-1403.
  • 8Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl,2002,8:765-774.
  • 9Shetty K, Timmins K, Brensinger C, et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl,2004,10:911-918.
  • 10Fernandez JA, Robles R, Marin C, et al. Can we expand the indications for liver transplantation among hepatocellular carcinoma patients with increased tumor size? Transplant Proc,2003,35:1818-1820.

共引文献143

同被引文献21

  • 1Ronald W. Busuttil.Liver transplantation for hepatocellular carcinoma: the Hangzhou experience[J].Hepatobiliary & Pancreatic Diseases International,2008,7(3):235-236. 被引量：16
  • 2蔡宇,蒲青凡,孙碎康,郑树森,金文扬,毛红,胡惠敏,张海峰,任瑞芳,潘继豹,黄海珍,王钱东,陈伟,叶溱.原位肝移植术后出凝血机制障碍并发症的预防[J].肝胆胰外科杂志,2005,17(1):74-75. 被引量：2
  • 3郑永顺,闫清,牛英,王尔顿,刘海春,陶国才.背驮式原位肝移植麻醉监测与管理[J].临床麻醉学杂志,2005,21(10):681-683. 被引量：11
  • 4蔡常洁,陆敏强,崇雨田,陈湖岸,陈规划.应用终末期肝病模型对慢性重型肝炎患者的预后评估[J].中华肝脏病杂志,2007,15(6):408-411. 被引量：9
  • 5Ruf AE, Kremers WK, Chavez LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl, 2005, 11: 336-343.
  • 6Biggins SW, Rodriguez HJ, Bacchetti P, et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology, 2005, 41: 32-39.
  • 7Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorpo- ration of serum sodium concentration into MELD. Gastroenterology, 2006, 130: 1652-1660.
  • 8Wong VW, Chim AM, Wong GL, et al. Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B. Liver Transpl, 2007, 13: 1228- 1235.
  • 9Bailey B, Amre DK, Gaudreault P. Fulminant hepatic failure secondary to acetaminophen poisoning: a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med, 2003, 31: 299-305.
  • 10Mazzaferro V, Regalia E, Doei R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med, 1996, 334: 693-699.

引证文献3

二级引证文献3

肝胆胰外科杂志
2007年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部